Related Experiment Video

Updated: Feb 28, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.2K

Alteration of DNA Methylation in Gastric Cancer with Chemotherapy

Su Jin Choi1, Seok Won Jung1, Sora Huh1

  • 1College of Pharmacy, Cancer Research Institute, Research Institute of Pharmaceutical Sciences and Institute for Microorganisms, Kyungpook National University, Daegu 41566, Republic of Korea.

Journal of Microbiology and Biotechnology
|June 17, 2017
PubMed

Insights

Epigenetic changes, particularly DNA methylation, drive cancer drug resistance. Targeting specific methylation patterns in gastric cancer may overcome resistance and improve patient outcomes.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • Epigenetic alterations, including DNA methylation, regulate gene expression and are crucial in cancer development.
  • Cancer cells develop drug resistance and evade cell death through epigenetic changes like DNA methylation.
  • Previous studies show hypermethylation of tumor suppressor genes and hypomethylation of oncogenes in cancer.

Purpose of the Study:

  • To identify genes with methylation patterns linked to anticancer drug resistance in gastric cancer.
  • To propose a novel epigenetic target for overcoming drug resistance in gastric cancer patients.

Main Methods:

  • Analysis of gene methylation status in relation to anticancer drug resistance.
  • Identification of specific epigenetic modifications associated with treatment outcomes.

Main Results:

  • Specific genes were identified whose methylation status correlates with drug resistance in gastric cancer.
  • These findings highlight the role of DNA methylation in acquired resistance to cancer therapies.

Conclusions:

  • DNA methylation changes are critical mediators of anticancer drug resistance in gastric cancer.
  • Targeting specific epigenetic modifications presents a promising strategy to enhance chemotherapy efficacy.
Keywords:
5-FUDNA methylationchemoresistancecisplatingastric cancer

More Related Videos

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.3K
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

3.2K

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.0K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.1K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
819
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K